Find Acecainide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 34118-92-8, N-acetylprocainamide hydrochloride, Acecainide hcl, Napa, Asl 601, Asl-601
Molecular Formula
C15H24ClN3O2
Molecular Weight
313.82  g/mol
InChI Key
IYEWBJUCJHKLHD-UHFFFAOYSA-N
FDA UNII
B9K738KX14

Acecainide
A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.
1 2D Structure

Acecainide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-acetamido-N-[2-(diethylamino)ethyl]benzamide;hydrochloride
2.1.2 InChI
InChI=1S/C15H23N3O2.ClH/c1-4-18(5-2)11-10-16-15(20)13-6-8-14(9-7-13)17-12(3)19;/h6-9H,4-5,10-11H2,1-3H3,(H,16,20)(H,17,19);1H
2.1.3 InChI Key
IYEWBJUCJHKLHD-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCN(CC)CCNC(=O)C1=CC=C(C=C1)NC(=O)C.Cl
2.2 Other Identifiers
2.2.1 UNII
B9K738KX14
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Acecainide

2. Acecainide Monohydrochloride

3. Acetylprocainamide

4. Hydrochloride, Acecainide

5. Monohydrochloride, Acecainide

6. N Acetylprocainamide

7. N-acetylprocainamide

2.3.2 Depositor-Supplied Synonyms

1. 34118-92-8

2. N-acetylprocainamide Hydrochloride

3. Acecainide Hcl

4. Napa

5. Asl 601

6. Asl-601

7. 4-acetamido-n-(2-(diethylamino)ethyl)benzamide Hydrochloride

8. Acecainide Hydrochloride [usan]

9. Nsc-759312

10. 4'-((2-(diethylamino)ethyl)carbamoyl)acetanilide Monohydrochloride

11. 34118-92-8 (hcl)

12. Mls000863278

13. Asl601;acecainide Hydrochloride

14. B9k738kx14

15. N-acetylprocainamide (hydrochloride)

16. Ncgc00093534-02

17. Dsstox_cid_25748

18. Dsstox_rid_81092

19. Dsstox_gsid_45748

20. Acecainide Hydrochloride (usan)

21. Benzamide, 4-(acetylamino)-n-(2-(diethylamino)ethyl)-, Monohydrochloride

22. Smr000059132

23. Cas-34118-92-8

24. Unii-b9k738kx14

25. Sr-01000000030

26. Einecs 251-831-2

27. Opera_id_64

28. Asl 601(acecainide)

29. Mls000028843

30. Mls001148141

31. Schembl122991

32. Spectrum2300154

33. Chembl1256805

34. Dtxsid1045748

35. Pharmakon1600-02300154

36. Bcp20733

37. Tox21_111206

38. Tox21_500009

39. Acecainide Hydrochloride [mi]

40. Nsc759312

41. Akos015888341

42. Tox21_111206_1

43. Ccg-213649

44. Lp00009

45. Nsc 759312

46. Acecainide Hydrochloride [mart.]

47. N-acetylprocainamide Hydrochloride, 99%

48. Ncgc00015072-10

49. Ncgc00093534-01

50. Ncgc00093534-03

51. Ncgc00260694-01

52. As-75674

53. Db-048569

54. Eu-0100009

55. Ft-0639157

56. A 5909

57. A20512

58. D02746

59. N16908

60. 4-acetamido-n-(2-(diethylamino)ethyl)benzamide Hcl

61. J-019456

62. Sr-01000000030-2

63. Acedainide; N-acetylnovocainamide Hydrochloride; Napa

64. Q27274550

65. 4-acetamido-n-(2-(diethylamino)ethyl)benzamidehydrochloride

66. N-acetylprocainamide Hydrochloride, >=99% (hplc), Powder

67. 4-acetamido-n-[2-(diethylamino)ethyl]benzamide;hydrochloride

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 313.82 g/mol
Molecular Formula C15H24ClN3O2
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count3
Rotatable Bond Count7
Exact Mass313.1557047 g/mol
Monoisotopic Mass313.1557047 g/mol
Topological Polar Surface Area61.4 Ų
Heavy Atom Count21
Formal Charge0
Complexity308
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Arrhythmia Agents

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty